Volume 55, Issue 6, Pages (June 1999)

Slides:



Advertisements
Similar presentations
Volume 70, Issue 7, Pages (October 2006)
Advertisements

Volume 67, Issue 2, Pages (February 2005)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Volume 62, Issue 5, Pages (November 2002)
UVB Increases Urokinase-Type Plasminogen Activator Receptor (uPAR) Expression1  Christoph Marschall, Toshiko Nobutoh, Evelyn Braungart, Kathrin Douwes,
Volume 58, Issue 5, Pages (November 2000)
Volume 60, Issue 2, Pages (August 2001)
Volume 53, Issue 5, Pages (May 1998)
Volume 76, Issue 7, Pages (October 2009)
Requirement of heat shock protein 90 in mesangial cell mitogenesis
Volume 55, Issue 5, Pages (May 1999)
Volume 58, Issue 5, Pages (November 2000)
Volume 60, Issue 5, Pages (November 2001)
Volume 55, Issue 1, Pages (January 1999)
Volume 54, Issue 1, Pages (July 1998)
Rat mesangial α-endosulfine
M.H.A. Baccora, P. Cortes, C. Hassett, D.W. Taube, J. Yee 
Volume 114, Issue 3, Pages (March 1998)
Volume 53, Issue 5, Pages (May 1998)
Xu Shi-wen, Christopher P. Denton, Alan M. Holmes, Carol M
Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration  Brenda B. Hoffman, Kumar Sharma,
Volume 56, Issue 3, Pages (September 1999)
Volume 67, Issue 6, Pages (June 2005)
Volume 56, Issue 4, Pages (October 1999)
Volume 58, Issue 4, Pages (October 2000)
Volume 65, Issue 1, Pages (January 2004)
Volume 59, Issue 1, Pages (January 2001)
Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells1  Gunter Wolf, Regine Schroeder, Fuad N.
Volume 61, Issue 5, Pages (May 2002)
Volume 62, Issue 5, Pages (November 2002)
Volume 54, Issue 6, Pages (January 1998)
Cell-Density-Dependent Regulation of Expression and Glycosylation of Dopachrome Tautomerase/Tyrosinase-Related Protein-2  Thomas J. Hornyak, Daniel J.
Volume 57, Issue 6, Pages (June 2000)
Volume 63, Issue 2, Pages (February 2003)
S.-M. Harwood, D.-A. Allen, M.-J. Raftery, M.M. Yaqoob 
Volume 54, Issue 1, Pages (July 1998)
Volume 54, Issue 4, Pages (October 1998)
Volume 58, Issue 3, Pages (September 2000)
Volume 55, Issue 4, Pages (April 1999)
Volume 57, Issue 4, Pages (April 2000)
Harald D. Rupprecht, M.D, Yoshitaka Akagi, Annette Keil, Gerhard Hofer 
Volume 67, Issue 2, Pages (February 2005)
Akito Maeshima, Yoshihisa Nojima, Itaru Kojima  Kidney International 
Volume 60, Issue 6, Pages (December 2001)
Vitamin D activates type A natriuretic peptide receptor gene transcription in inner medullary collecting duct cells  S. Chen, K. Olsen, C. Grigsby, D.G.
Volume 58, Issue 4, Pages (October 2000)
DNA binding of activator protein-1 is increased in human mesangial cells cultured in high glucose concentrations  William A. Wilmer, Fernando G. Cosio 
Volume 53, Issue 4, Pages (April 1998)
Volume 56, Issue 2, Pages (August 1999)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 59, Issue 5, Pages (May 2001)
Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress  Marjorie E. Dunlop,
Volume 58, Issue 3, Pages (September 2000)
Volume 56, Issue 5, Pages (November 1999)
Post-Transcriptional Regulation of UV Induced TNF-α Expression
Volume 70, Issue 5, Pages (September 2006)
Angiotensin III increases MCP-1 and activates NF-кB and AP-1 in cultured mesangial and mononuclear cells  Marta Ruiz-Ortega, Oscar Lorenzo, Jesus Egido 
Volume 56, Issue 6, Pages (December 1999)
Volume 59, Issue 2, Pages (February 2001)
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 53, Issue 6, Pages (June 1998)
Volume 55, Issue 2, Pages (February 1999)
Volume 62, Issue 4, Pages (October 2002)
Volume 65, Issue 3, Pages (March 2004)
Volume 55, Issue 4, Pages (April 1999)
J. Martin, T. Bowen, R. Steadman  Kidney International 
Aluminum is a weak agonist for the calcium-sensing receptor
Volume 62, Issue 5, Pages (November 2002)
Differential effects of simvastatin on mesangial cells
Volume 57, Issue 1, Pages (January 2000)
Presentation transcript:

Volume 55, Issue 6, Pages 2289-2298 (June 1999) Characterization of the rat mesangial cell type 2 sulfonylurea receptor  Kenichiro Asano, Pedro Cortes, Jeffrey L. Garvin, Bruce L. Riser, Alicia Rodríguez-Barbero, Balázs Szamosfalvi, Jerry Yee  Kidney International  Volume 55, Issue 6, Pages 2289-2298 (June 1999) DOI: 10.1046/j.1523-1755.1999.00485.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Identification of a high-affinity, hamster insulinoma tumor β cell line (HIT) cell sulfonylurea receptor. Two hundred micrograms of HIT and mesangial cell (MC) membrane proteins were incubated at 25°C for 60minutes with increasing amounts of [3H]glibenclamide at a constant specific activity of 50 μCi/nmol during equilibrium radioligand binding studies. The results of a representative experiment are shown (N = 2). Specific binding of ligand (○) was calculated following the subtraction of nonspecific binding (▴) from total binding (•). Specific saturable binding of glibenclamide to HIT cell membranes is depicted (A) with a Scatchard plot of the binding data (inset). Nonspecific binding to MC membranes (B) is evident over the concentration range shown (N = 2). However, no specific binding (○) to MC membranes is demonstrated. Kidney International 1999 55, 2289-2298DOI: (10.1046/j.1523-1755.1999.00485.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Identification of a low-affinity mesangial cell sulfonylurea receptor. Five hundred microgram samples of MC membrane proteins were used for binding studies, using increasing concentrations of glibenclamide according to the methodology described in Figure 1, except that the specific activity of the sulfonylurea was 2 μCi/nmol. Total binding (•), nonspecific binding (▴), and specific saturable binding (○) of [3H]glibenclamide to MC membranes are shown. A Scatchard plot of the binding data and apparent values for binding parameters are shown (inset). Each data point represents the pooled results obtained in four independent experiments. In each experiment, samples were tested in duplicate. Values are expressed as means ± se. Except for the lowest amount tested (0.2 μm), differences between specific and nonspecific binding are statistically significant (P < 0.05) at all concentrations. Kidney International 1999 55, 2289-2298DOI: (10.1046/j.1523-1755.1999.00485.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 Mesangial SUR2 gene expression. In Northern analysis, 20 μg quantities of total RNAs extracted from rat MCs, brain, heart, and kidney and mouse kidney fibroblasts were probed with rat SUR2 cDNA (A). In brain, heart, and kidney, hybridization at 7.5kb was detected after 16hours of autoradiography. In MCs, a major transcript appeared at 5.5kb and a minor transcript at 8.6kb. SUR2 transcripts were not detected in renal fibroblasts. In a separate experiment (B), after 72hours of autoradiographic exposure, we reproducibly hybridized three mesangial transcripts at 5.5, 7.5, and 8.6kb with the rat SUR2 cDNA used in (A). Kidney International 1999 55, 2289-2298DOI: (10.1046/j.1523-1755.1999.00485.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 4 Glibenclamide-induced Ca2+ transients in mesangial cells. The changes in the mesangial cell fluorescence ratio A340/380 over a 15-minute time course are shown. Following loading of subconfluent mesangial cell cultures with fura-2 dye, cells were incubated at 37°C in an incubation/observation chamber irrigated by a perfusion solution containing 1% FCS. A representative experiment is shown in which three cells were marked, and then spectrofluorometric measurements were obtained after the addition of glibenclamide to the perfusion reservoir at t = -5minutes. At t = -2.5minutes, small initial spikes representing increases in Ca2+ concentration were demonstrated in all three cells, as glibenclamide entered the incubation/observation chamber. Glibenclamide concentration in the chamber's incubation solution reached a maximum 2.5minutes later at t = 0min (arrow). Ca2+ transients in all observed cells oscillated synchronously at two- to three-minute intervals following exposure to glibenclamide until the end of the observation period. Kidney International 1999 55, 2289-2298DOI: (10.1046/j.1523-1755.1999.00485.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 5 Glibenclamide-induced mesangial cell contraction. Subconfluent cultures of mesangial cells were grown on polymerized dimethylpolysiloxane membranes and were then serum deprived for 24hours at 37°C. Cells were then perfused with glibenclamide in 0.1% FCS to achieve a final concentration of 5 μm during continuous videomicroscopic recording. Cell contractions (arrowheads) and new glibenclamide-induced wrinkle formations that deformed the silicon rubber substrate (arrows) are shown at 0 (A), 10 (B), and 20minutes (C). Kidney International 1999 55, 2289-2298DOI: (10.1046/j.1523-1755.1999.00485.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 6 Degree of glibenclamide-induced mesangial cell contraction. Cells were grown on grid-marked cover slips coated with a dimethylpolysiloxane substrate under the same conditions as in Figure 5. In each experiment, the exact locations of 30 to 50 cells were identified, and the corresponding degree of wrinkling produced by each cell was quantitated at baseline and after 20minutes of exposure to 5 μm glibenclamide (N = 8). Control (□, N = 5) and glibenclamide-treated cells (▪, N = 8) were classified as contracted, detached, no change, or relaxed after comparison to baseline. *P < 0.05; †P < 0.005; §P < 0.002. Kidney International 1999 55, 2289-2298DOI: (10.1046/j.1523-1755.1999.00485.x) Copyright © 1999 International Society of Nephrology Terms and Conditions